Drug prices in advertisements actually hurt consumers

Washington Examiner

23 October 2018 - This month, the Trump administration proposed a new rule that would require advertisements for prescription drugs covered by Medicare or Medicaid to include the list price of the medicine.

To be sure, a free market is dependent on consumers making informed decisions. But this move would provide patients with incomplete, misleading numbers that would muddle their healthcare decisions.

Patients almost never pay the full list price for their medication. After a drug is manufactured by a pharmaceutical company, its price and distribution are influenced by numerous intermediaries.

Read Washington Examiner article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , US , Transparency , Advertising